Review Article

Analysis of Gynecologic Cancer Management at Sanglah Hospital during COVID- 19 Pandemic

I Gde Sastra Winata
Medical Faculty of Udayana University, Indonesia
* Corresponding author
Ngakan Ketut Darmawan
Medical Faculty of Udayana University, Indonesia
I Nyoman Gede Budiana
Medical Faculty of Udayana University, Indonesia
I Nyoman Bayu Mahendra
Medical Faculty of Udayana University, Indonesia
DOI icon 10.24018/ejmed.2022.4.2.1283

Read Counter
606

Downloads
209

Citations

Share

Article Sidebar

Submitted 2022-03-18
Published 2022-04-15

Read counter = 606 times

Table of Contents

Article Main Content

The COVID-19 pandemic presents its own challenges in treating cancer, especially gynecological cancer. The condition of cancer patients who have been immunocompromised either because of their disease or side effects of the drugs given, has the potential to increase the risk of cancer patients to experience severe COVID-19 infection. The main management of cancer, which is based on three axes, namely surgery, chemotherapy, and radiotherapy, needs to be adapted to increase survival rates. rates in patients.

Keywords: COVID-19, chemotherapy, gynecological cancer, operative, radiotherapy

References

  1. Jee Y. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak. Epidemiol Health. 2020; 42: e2020013.
    DOI  |   Google Scholar
  2. Akladios C, Azais H, Ballester M, Bendifallah S, Bolze P-A, Bourdel N, et al. Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic-FRANCOGYN group for the CNGOF. J Gynecol Obstet Hum Reprod. 2020; 49(6): 101729.
    DOI  |   Google Scholar
  3. Anthony C, Ezugwu FO, Lawani OL. Challenges associated with the management of gynecological cancers in a tertiary hospital in South East Nigeria. Int J Womens Health. 2014; 6: 123–30.
    DOI  |   Google Scholar
  4. Alkatout I, Karimi-Zarchi M, Allahqoli L. Gynecological cancers and the global COVID-19 pandemic. J Turk Ger Gynecol Assoc. 2020; 21(4): 272-278.
    DOI  |   Google Scholar
  5. Pothuri B, Alvarez A, Armstrong DK, Chan J, Fader AN, Huh W, et al. Gynecologic Oncology Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis. Gynecol Oncol. [Internet]. 2020; (xxxx). Available from: https://doi.org/10.1016/j.ygyno.2020.04.694
    DOI  |   Google Scholar
  6. Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, et al. Gynecologic Oncology Radiation therapy for gynecologic malignancies during the COVID-19 pandemic : International expert consensus recommendations. Gynecol Oncol. [Internet]. 2020; Available from: https://doi.org/10.1016/j.ygyno.2020.06.486
    DOI  |   Google Scholar
  7. Ramirez PT, Chiva L, Eriksson AGZ, Frumovitz M, Fagotti A, Martin AG, et al. COVID-19 global pandemic: options for management of gynecologic cancers. BMJ Specialist Journals. 2020.
    DOI  |   Google Scholar
  8. Fader AN, Huh WK, Kesterson J, Pothuri B, Wethington S, Wright JD, et al. When to operate, hesitate and reintegrate: society of gynecologic oncology surgical considerations during the COVID-19 pandemic. Gynecol Oncol. 2020; 158(2): 236–43.
    DOI  |   Google Scholar


Most read articles by the same author(s)

1 2 3 > >>